[1]
|
Zhu, W., Cheng, S., Xu, G., Ma, M., Zhou, Z., Liu, D. and Liu, X. (2011) Intranasal Nerve Growth Factor Enhances Striatal Neurogenesis in Adult Rats with Focal Cerebral Ischemia. Drug Delivery, 18, 338-343.
https://doi.org/10.3109/10717544.2011.557785
|
[2]
|
Yang, J.P., Liu, H.J., Yang, H. and Feng, P.Y. (2011) Therapeutic Time Window for the Neuroprotective Effects of NGF When Administered after Focal Cerebral Ischemia. Neurological Sciences, 32, 433-441.
https://doi.org/10.1007/s10072-011-0512-9
|
[3]
|
Yu, S.J., Tseng, K.Y., Shen, H., Harvey, B.K., Airavaara, M. and Wang, Y. (2013) Local Administration of AAV-BDNF to Subventricular Zone Induces Functional Recovery in Stroke Rats. PLoS ONE, 8, 1-8.
https://doi.org/10.1371/journal.pone.0081750
|
[4]
|
Ploughman, M., Windle, V., MacLellan, C.L., White, N., Doré, J.J. and Corbett, D. (2009) Brain-Derived Neurotrophic Factor Contributes to Recovery of Skilled Reaching after Focal Ischemia in Rats. Stroke, 40, 1490-1495.
https://doi.org/10.1161/STROKEAHA.108.531806
|
[5]
|
Zhao, H., Liu, X., Mao, X. and Chen, C. (2004) Intranasal Delivery of Nerve Growth Factor to Protect the Central Nervous System against Acute Cerebral Infarction. Chinese Medical Science Journal, 19, 257-261.
|
[6]
|
Hassanzadeh, P., Arbabi, E., Atyabi, F. and Dinarvand, R. (2017) Nerve Growth Factor-Carbon Nanotube Complex Exerts Prolonged Protective Effects in an in Vitro Model of Ischemic Stroke. Life Sciences, 179, 15-22.
https://doi.org/10.1016/j.lfs.2016.11.029
|
[7]
|
Chen, A., Xiong, L.-J., Tong, Y. and Mao, M. (2013) The Neuro-protective Roles of BDNF in Hypoxic Ischemic Brain Injury. Biomedical Reports, 1, 167-176. https://doi.org/10.3892/br.2012.48
|
[8]
|
Schabitz, W.R., Steigleder, T., Cooper-Kuhn, C.M., Schwab, S., Sommer, C., Schneider, A. and Kuhn, H.G. (2007) Intravenous Brain-Derived Neurotrophic Factor Enhances Poststroke Sensorimotor Recovery and Stimulates Neurogenesis. Stroke, 38, 2165-2172. https://doi.org/10.1161/STROKEAHA.106.477331
|
[9]
|
Guan, J., Tong, W., Ding, W., Du, S., Xiao, Z., Han, Q., Zhu, Z., Bao, X., Shi, X., Wu, C., Cao, J., Yang, Y., Ma, W., Li, G., Yao, Y., Gao, J., Wei, J., Dai, J. and Wang, R. (2012) Neuronal Regeneration and Protection by Collagen-Binding BDNF in the Rat Middle Cerebral Artery Occlusion Model. Biomaterials, 33, 1386-1395.
https://doi.org/10.1016/j.biomaterials.2011.10.073
|
[10]
|
Oliveira, S.L.B., Pillat, M.M., Cheffer, A., Lameu, C., Schwindt, T.T. and Ulrich, H. (2013) Functions of Neurotrophins and Growth Factors in Neurogenesis and Brain Repair. Cytometry Part A, 83, 76-89.
https://doi.org/10.1002/cyto.a.22161
|
[11]
|
Jiang, Y., Wei, N., Zhu, J., Lu, T., Chen, Z., Xu, G. and Liu, X. (2010) Effects of Brain-Derived Neurotrophic Factor on Local Inflammation in Experimental Stroke of Rat. Mediators of Inflammation, 2010, Article ID 372423. https://doi.org/10.1155/2010/372423
|
[12]
|
Gudasheva, T.A., Antipova, T.A. and Seredenin, S.B. (2010) Novel Low-Molecular-Weight Mimetics of the Nerve Growth Factor. Doklady Biochemistry and Biophysics, 434, 262-265.
https://doi.org/10.1134/S160767291005011X
|
[13]
|
Gudasheva, T.A., Tarasyuk, A.V., Pomogaibo, S.V., Logvi-nov, I.O., Povarnina, P.Y., Antipova, T.A. and Seredenin, S.B. (2012) Design and Synthesis of Dipeptide Mimetics of the Brain-Derived Neurotrophic Factor. Russian Journal of Bioorganic Chemistry, 38, 243-252. https://doi.org/10.1134/S1068162012030053
|
[14]
|
Gudasheva, T.A., Povarnina, P.Y., Antipova, T.A., Firsova, Y.N., Konstantinopolsky, M.A. and Seredenin, S.B. (2015) Dimeric Dipeptide Mimetics of the Nerve Growth Factor Loop 4 and Loop 1 Activate TRKA with Different Patterns of Intracellular Signal Transduction. Journal of Biomedical Science, 22, 106.
https://doi.org/10.1186/s12929-015-0198-z
|
[15]
|
Gudasheva, T.A., Povarnina, P., Logvinov, I.O., Antipova, T.A. and Seredenin, S.B. (2016) Mimetics of Brain-Derived Neurotrophic Factor Loops 1 and 4 Are Active in a Model of Ischemic Stroke in Rats. Drug Design, Development and Therapy, 10, 3545-3553. https://doi.org/10.2147/DDDT.S118768
|
[16]
|
Longa, E.Z., Weinstein, P.R., Carlson, S. and Cummins, R. (1989) Reversible Middle Cerebral Artery Occlusion without Craniectomy in Rats. Stroke, 20, 84-91. https://doi.org/10.1161/01.STR.20.1.84
|
[17]
|
Povarnina, P.Y., Vorontsova, O.N., Gudasheva, T.A., Ostrovskaya, R.U. and Seredenin, S.B. (2013) Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer’s Disease. Acta Naturae, 18, 84-91.
|
[18]
|
Kaplan, D.R. and Miller, F.D. (2000) Neurotrophin Signal Transduction in the Nervous System. Current Opinion in Neurobiology, 10, 381-391. https://doi.org/10.1016/S0959-4388(00)00092-1
|
[19]
|
Crowder, R.J. and Freeman, R.S. (1998) Phosphatidylino-sitol 3-Kinase and Akt Protein Kinase are Necessary and Sufficient for the Survival of Nerve Growth Factor-Dependent Sympathetic Neurons. The Journal of Neuroscience, 18, 2933-2943. http://www.ncbi.nlm.nih.gov/pubmed/9526010
https://doi.org/10.1523/JNEUROSCI.18-08-02933.1998
|
[20]
|
Liu, L., Sun, T., Xin, F., Cui, W., Guo, J. and Hu, J. (2017) Nerve Growth Factor Protects against Alcohol-Induced Neurotoxicity in PC12 Cells via PI3K/Akt/mTOR Pathway. Alcohol and Alcoholism, 52, 12-18.
https://doi.org/10.1093/alcalc/agw077
|
[21]
|
Salinas, M., Diaz, R., Abraham, N.G., De Galarreta, C.M.R. and Cuadrado, A. (2003) Nerve Growth Factor Protects Against 6-Hydroxydopamine-Induced Oxidative Stress by Increasing Expression of Heme Oxygenase-1 in a Phosphatidylinositol 3-Kinase-Dependent Manner. The Journal of Biological Chemistry, 278, 13898-13904.
https://doi.org/10.1074/jbc.M209164200
|
[22]
|
Obata, K. and Noguchi, K. (2004) MAPK Activation in Nociceptive Neurons and Pain Hypersensitivity. Life Sciences, 74, 2643-2653. https://doi.org/10.1016/j.lfs.2004.01.007
|
[23]
|
Nakazawa, T., Tamai, M. and Mori, N. (2002) Brain-Derived Neurotrophic Factor Prevents Axotomized Retinal Ganglion Cell Death through MAPK and PI3K Signaling Pathways. Investigative Ophthalmology & Visual Science, 43, 3319-3326. http://www.ncbi.nlm.nih.gov/pubmed/12356841
|
[24]
|
Almeida, R.D., Manadas, B.J., Melo, C.V., Gomes, J.R., Mendes, C.S., Graos, M.M., Carvalho, R.F., Carvalho, A.P. and Duarte, C.B. (2005) Neuroprotection by BDNF against Glutamate-Induced Apoptotic Cell Death Is Mediated by ERK and PI3-Kinase Pathways. Cell Death and Differentiation, 12, 1329-1343.
https://doi.org/10.1038/sj.cdd.4401662
|
[25]
|
Hetman, M., Kanning, K., Cavanaugh, J.E. and Xia, Z. (1999) Neuroprotection by Brain-Derived Neurotrophic Factor Is Mediated by Extracellular Signal-Regulated Kinase and Phosphatidylinositol 3-Kinase. The Journal of Biological Chemistry, 274, 22569-22580. https://doi.org/10.1074/jbc.274.32.22569
|
[26]
|
Seredenin, S.B., Voronina. T.A., Gudasheva, T.A., Garibova, T.L., Molodavkin, G.M., Litvinova, S.A., Elizarova, E.A. and Poseva, V.I. (2013) Antidepressant Effect of Dimeric Dipeptide GSB-106, an Original Low-Molecular-Weight Mimetic of BDNF. Acta Naturae, 5, 105-109.
|
[27]
|
Qiao, L.Y., Yu, S.J., Kay, J.C. and Xia, C.M. (2013) In Vivo Regulation of Brain-Derived Neurotrophic Factor in Dorsal Root Ganglia Is Mediated by Nerve Growth Factor-Triggered Akt Activation During Cystitis. PLoS ONE, 8, e81547. https://doi.org/10.1371/journal.pone.0081547
|